ANDA 74936, held by Actavis Elizabeth. Naproxen.
As of Nov 14, 2026, ANDA 74936 (Naproxen), held by Actavis Elizabeth, was first approved by FDA on Feb 24, 1998, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 24, 1998 | Original application | Approved |
| Nov 2, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Mar 5, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Feb 24, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
